K150235

Substantially Equivalent

CLEARSIGN II Amplifier, 40 channels, CLEARSIGN II Amplifier, 80 channels, CLEARSIGN II Amplifier, 120 channels, CLEARSIGN II Amplifer, 160 channels

Applicant: Boston Scientific Corporation
Product code: DRQ
Advisory panel: Cardiovascular
Date received: 2015-02-02
Decision date: 2015-04-22
Decision: Substantially Equivalent
Clearance type: Special
Location: Lowell, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.